Viewing Study NCT05967351


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2025-12-25 @ 9:48 PM
Study NCT ID: NCT05967351
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-01-17
First Post: 2023-07-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
Sponsor: Sarepta Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module